Category Archives: Licensing

DC decisions of induced infringement of patent asserted by Meso and non-infringement of non-asserted patents as requested by Roche vacated and remanded

Posted on April 15, 2022 by Patrick J. Halloran, Ph.D., J.D.

Roche Diagnostics Corp., Bioveris Corp. v. Meso Scale Diagnostics, LLC Docket No. 2021-1609, -1633 (https://cafc.uscourts.gov/opinions-orders/21-1609.OPINION.4-8-2022_1933410.pdf) NEWMAN (D), PROST, TARANTO April 8, 2022 Brief Summary:   DC findings of induced infringement of patents asserted by Meso and non-infringement of non-asserted patents … Continue reading →

Posted in Assignment / Ownership, Damages, Inducement to Infringe, Infringement, Licensing | Leave a comment

DC reversed on WD of genus claims and patent co-ownership, affirmed on no willfulness and remanded for damages calculation

Posted on March 28, 2022 by Patrick J. Halloran, Ph.D., J.D.

BASF Plant Science, L.P., Cargill, Inc. v. Commonwealth Scientific, et al. (“CSIRO”) Docket No. 2020-1415-16, 2020-1919-20 (https://cafc.uscourts.gov/opinions-orders/20-1415.OPINION.3-15-2022_1921729.pdf) NEWMNA (D), TARANTO, CHEN March 15, 2022 Brief Summary:   Following a dispute regarding a collaboration agreement, FC panel affirmed DC fining on … Continue reading →

Posted in Assignment / Ownership, Infringement, Inventorship, Licensing, Royalties, Venue, Willfullness, Written description | Leave a comment

DC denial of preliminary injunction reversed as Sarepta’s IPR filings violated forum selection clause

Posted on March 9, 2022 by Patrick J. Halloran, Ph.D., J.D.

Nippon Sinyaku Co., Ltd. v. Sarepta Therapeutics, Inc. Docket No. 2021-2369 (https://cafc.uscourts.gov/opinions-orders/21-2369.OPINION.2-8-2022_1904898.pdf) NEWMAN, LOURIE, STOLL February 8, 2021 Brief Summary:  DC denial of preliminary injunction against Sarepta’s IPR filings reversed. Summary:  Nippon appealed from DC DE decision denying its motion … Continue reading →

Posted in Inter Parties Review (IPR), IPR, Licensing | Leave a comment

DC grant of Plasmacam’s motion to enforce its version of a settlement agreement reversed and remanded

Posted on February 24, 2022 by Patrick J. Halloran, Ph.D., J.D.

Plasmacam, Inc. v. CNCelectronics, LLC et al. Docket No. 2021-1689 (https://cafc.uscourts.gov/opinions-orders/21-1689.OPINION.2-3-2022_1902753.pdf) NEWMAN, DYK, REYNA February 3, 2021 Brief Summary:  DC grant of Plasmacam’s motion to enforce its version of a settlement agreement reversed and remanded. Summary:  CNC appealed DC grant … Continue reading →

Posted in Appeal, Article III disputes, Licensing | Leave a comment

Damages to inventor affirmed; award to Plastronics reversed due to Texas statute of limitations

Posted on January 28, 2022 by Patrick J. Halloran, Ph.D., J.D.

Plastronics Socket Partner, Ltd. et al. v. Dong Weon Hwang, HiCon Co., Ltd. et al. Docket No. 2020-1739, -1781 (https://cafc.uscourts.gov/opinions-orders/20-1739.OPINION.1-12-2022_1892222.pdf) (Non-Precedential) DYK, HUGHES, STOLL January 12, 2022 Brief Summary:  DC award of breach of contract damages to inventor affirmed; award … Continue reading →

Posted in Damages, Licensing, Royalties | Leave a comment

DC finding that Polymetrix did not induce importation of samples into the US affirmed

Posted on December 27, 2021 by Patrick J. Halloran, Ph.D., J.D.

Alpek Polyester, S.A., DAK Americas LLC, et al. v. Polymetrix AG Docket No. 2021-1706 (https://cafc.uscourts.gov/opinions-orders/21-1706.OPINION.12-16-2021_1880727.pdf) (Non-precedential) LOURIE, O’MALLEY, STOLL December 16, 2021 Brief Summary:  DC grant of SJ of no induced infringement by importation affirmed. Summary:  Alpek/DAK appealed DC grant … Continue reading →

Posted in Importation, Inducement to Infringe, Infringement, Licensing | Leave a comment

Apple’s appeals of IPR decisions dismissed for lack of Article III standing

Posted on May 4, 2021 by Patrick J. Halloran, Ph.D., J.D.

Apple Inc. v. Qualcomm Incorporated Docket No. 2020-1561, -1642 (IPR2018-01279, -01252) (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1561.OPINION.4-7-2021_1759839.pdf) MOORE, REYNA, HUGHES April 7, 2021 Brief Summary:  Apple’s appeal of IPR FWDs dismissed due to global settlement agreement with Qualcomm (e.g., “displeasure with a license provision” does … Continue reading →

Posted in Appeal, Article III disputes, Inter Parties Review (IPR), IPR, Licensing | Leave a comment

DC erred in denying ownership of foreign patents arising from non-disclosure agreement

Posted on December 10, 2020 by Patrick J. Halloran, Ph.D., J.D.

SiOnyx LLC et al. v. Hamamatsu Photonics K.K. et al. Docket No. 2019-2359, 2020-1217 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/19-2359.OPINION.12-7-2020_1697100.pdf) LOURIE, REYNA, WALLACH December 7, 2020 Brief Summary:  DC erred in failing to transfer ownership of foreign patents arising from confidential information disclosed under an … Continue reading →

Posted in Assignment / Ownership, Damages, Licensing, Unjust enrichment | Leave a comment

Infringement by GSK’s inhalers and damages determination affirmed

Posted on November 27, 2020 by Patrick J. Halloran, Ph.D., J.D.

Vectura Limited v. GlaxoSmithKline LLC et al. Docket No. 2020-1054 (http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/20-1054.OPINION.11-19-2020_1688174.pdf) PROST, BRYSON, WALLACH November 19, 2020 Brief Summary:  DC finding that GSK’s inhaler composition infringe Vectura’s patent and the ~$90 million damages award affirmed. Summary:  GSK appealed jury finding … Continue reading →

Posted in Claim Construction, Damages, Licensing | Leave a comment

DC grant of SJ affirmed due to “an unenforceable agreement to agree”

Posted on September 7, 2020 by Patrick J. Halloran, Ph.D., J.D.

Phytelligence, Inc. v. Washington State UniversityDocket No. 2019-2216PROST, REYNA, STOLLAugust 27, 2020 Brief Summary: DC grant of SJ to WSU affirmed since option agreement was “an unenforceable agreement to agree”, not an “agreement with open terms” that could be deciphered … Continue reading →

Posted in Licensing, Uncategorized | Leave a comment